PANS/PANDAS - Autism Research Institute https://autism.org/category/pans-pandas/ Advancing Autism Research and Education Mon, 25 Aug 2025 16:40:19 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.4 Research Updates: At the Crossroads of Infection, Inflammation, and Mental Health https://autism.org/pans-updates/ Sat, 18 Jan 2025 20:29:25 +0000 https://autism.org/?p=18685 Jennifer Frankovich, MD, MS, dives into the intersection of infection, inflammation, and mental health. She discusses the increase in recognition of this critical overlap over the last decade, highlighting how systemic inflammatory conditions have the highest rate of co-occurring psychiatric disorders. The speaker outlines ten inflammatory diseases that frequently co-occur with

The post Research Updates: At the Crossroads of Infection, Inflammation, and Mental Health appeared first on Autism Research Institute.

]]>

Jennifer Frankovich, MD, MS, dives into the intersection of infection, inflammation, and mental health. She discusses the increase in recognition of this critical overlap over the last decade, highlighting how systemic inflammatory conditions have the highest rate of co-occurring psychiatric disorders. The speaker outlines ten inflammatory diseases that frequently co-occur with mental health conditions, including spondyloarthritis, psoriasis/psoriatic arthritis, Behçet’s Syndrome, Sjögren’s disease, Scleroderma, CNS Vasculitis, Sydenhams’ Chorea, and Lupus. Frankovich underscores the connection of Streptococcal infections to many of these inflammatory conditions, noting their similarities to PANS and challenges with diagnosis. She provides thanks and acknowledgments before the Q&A. 

This is a follow-up to our June 12, 2024 webinar featuring Dr. Jennifer Frankovich, Ayan Mondal, Ph.D., and Noor A. Hussein, Ph.D.

In this Webinar

1:20 – Inflammation and mental health
3:50 – Spondyloarthritis (SpA)
11:00 – Psoriasis/Psoriatic Arthritis
16:05 – Behçet’s Syndrome
19:25 – Brain parenchymal disease
21:15 – Non-parenchymal disease
22:25 – Sjögren’s disease
24:05 – Scleroderma
25:50 – CNS Vasculitis
26:25 – Sydenhams’ Chorea
37:00 – Erythema Marginatum
38:50 – Strep infections and mental health
42:00 – Lupus
44:55 – Q&A

Inflammation and mental health

Over the last decade, recognition of the overlap between rheumatological/inflammatory disorders and mental health conditions has significantly increased. Frankovich notes common inflammatory diseases that co-occur with psychiatric symptoms, including those caused by small-vessel vasculitis, autoimmune encephalitis, basal ganglia inflammation, and white matter inflammation (1:20). Most commonly, she continues, systemic inflammatory conditions like psoriasis/psoriatic arthritis, and irritable bowel syndrome (IBS) have the highest rates of co-occurring psychiatric disorders (3:30). She outlines ten (10) specific disorders, how they present, and how clinicians/practitioners can test for them.

The odd couple?—Hardly: The emerging overlap between rheumatology and psychiatry (Taylor & Jain, 2017)

Spondyloarthritis 

Spondyloarthritis (SpA) can cause microscopic spinal inflammation that is not often perceptible on imaging until decades later. It is characterized by pain and stiffness in the morning and after prolonged stationary positions. Frankovich explains that 40% of patients with SpA also experience depression, anxiety, fatigue, and brain fog and that adults with SpA have a higher prevalence of OCD, anger/hostility, and deliberate self-harm versus controls (3:50). The speaker notes that children with psychiatric diagnoses may not be able to articulate pain and stiffness, so practitioners must look for clues such as stiffness walking, axial and peripheral stiffness, iliac pain and tenderness, and specific foot pains. Psoriasis and bowel inflammation also commonly co-occur with SpA. Frankovich underscores the high heritability of SpA and suggests observing parental symptoms when diagnosing children (7:15)

Psoriasis/Psoriatic Arthritis

Psoriasis and psoriatic arthritis have significant overlap with psychiatric disorders, especially bipolar, depression, and anxiety. The speaker explains that pain from arthritis can seem out of proportion, so patients are often dismissed. Frankovich notes specific ultrasounds that can be used to identify inflammation in discrete areas of the body and reiterates how psychiatric conditions may keep patients, especially children, from complaining of their pain, making a diagnosis even more challenging (11:00). Common sites for psoriasis include behind the ears, on the scalp, around the belly button. She warns against mistaking Onycholysis for fungal nail infections and notes that streptococcal infections can trigger arthritis flares (13:35)

Behçet’s Syndrome

The speaker describes Behçet’s Syndrome as a multisystem inflammatory disease where 10% of patients have neurological diseases perceptible on an MRI and 40% have psychiatric disorders. Other symptoms can include recurrent oral ulcers, ocular inflammation in the anterior portion of the eye, and potential scarring from genital ulcers. Behçet’s Syndrome is a type of transient arthritis where flareups, often triggered by intense immune responses to infection, can last from one to three weeks (16:05). Frankovich notes that when vascular inflammation is present in both arteries and veins, this nearly always indicates Behçet’s Syndrome. Pathergy, or blistering at the blood draw site, is also a strong indicator (18:25)

Brain parenchymal disease

Brain parenchymal disease (BPD) is characterized by a subacute onset of multi-focal inflammatory legions, which an MRI can miss if it is not conducted at the time of a new deficit. In many cases, the MRI reflects non-specific white matter changes that do not rule out BPD in and of themselves. Some patients also suffer from headaches, behavior changes, and cognitive dysfunction, which can lead to temporary encephalopathy, seizures, and psychosis. The presenter underscores the importance of early diagnosis and treatment but notes that BPD is difficult to diagnose because legions are temporary and appear in different places each time (19:25)

Non-parenchymal disease

Non-parenchymal diseases involve the brain’s venous systems. Cerebral venous thrombosis, or severe headaches, must be assessed using imaging that highlights the venous system (e.g., MRV). Non-parenchymal diseases often co-occur with fibromyalgia (18 – 37%), parietal cell autoantibodies, vitamin deficiencies (especially B,) and bowel ulcers or IBS (21:15)

Sjögren’s disease

Frankovich defines Sjögren’s disease as a systemic rheumatologic condition that often presents with dry eyes and mouth and a lot of autonomic nervous system dysfunction such as altered vascular tone, esophageal contractility (trouble swallowing), cardiac rhythm abnormalities, and neuropathic symptoms (i.e., burning, tingling, or numbness). Co-occurring psychiatric disorders make it challenging to self-advocate. The speaker suggests running a mucosal biopsy of the lip to assess salivary gland inflammation if Sjögren’s disease is suspected (22:25)

Scleroderma

Scleroderma is a systemic sclerosis that causes widespread vascular dysfunction and progressive fibrosis of the skin and internal organs. Over many years, the speaker explains, a person’s skin starts to harden. Early signs in children include Raynauds (cold, white hands) and abnormal nail fold capillaroscopic. She highlights that manifestation may precede the full disease by years, so it is critical to follow patients closely (24:05)

Personality structure disturbances and psychiatric manifestations in primary Sjögren’s syndrome (Drosos et al., 1989)

CNS Vasculitis

CNS vasculitis is a very rare type of inflammation focused on the brain. It is perceptible on MRI scans and should be considered when children present with new-onset headaches and behavior changes (25:50)

The spectrum of CNS vasculitis in children and adults (Twilt & Benseler, 2012)

Sydenhams’ Chorea

Sydenhams’ Chorea (SC) presents with three critical components: emotional lability, hypotonia (weak muscles), and chorea (involuntary, brief, random, and irregular movements of the limbs and face). In children, this can look like continuous restlessness (26:25). Frankovich explains that accompanying psychiatric symptoms are similar to what we see in PANS. For example, 60% of patients with SC have OCD at onset, and 100% have it at relapse. Other symptoms include outbursts of inappropriate behavior or mismatched emotions (easy crying or inappropriate laughing), irrational fears that can lead to delusions, anxiety, personality changes, and night terrors (28:08). Other presentations include difficulty keeping arms up or hyperactive reflexes (33:40)

The presenter notes that the line between what is and is not SC is very blurry, making it hard to detect and diagnose. One of the earliest studies (1926) notes that, in children, nuanced chorea is always Sydenhams, so practitioners should always treat for strep infection and clear it out of the house. According to the study, emotional lability is the most constant observation, along with extreme personality changes where individuals become aggressive and irritable, which is very similar to how PANS presents (30:00)

Children often cover up their chorea, so clinicians must actively look for muscle use abnormalities. Simple tests for chorea include the milkmaid’s grip and darting tongue. Because psychiatric symptoms like OCD can start two to four weeks before chorea, children who present with acute-onset OCD should be re-evaluated over at least one month (31:25). The onset of chorea can occur anywhere between one and eight months after a strep infection, meaning that ASO and DNASE titers may be normal during assessments (33:40)

The presence of acute rheumatic fever can also support an SC diagnosis, but it is not necessary. However, the speaker warns that mild cases of SC without other manifestations of acute rheumatic fever may be mistakenly ascribed to behavior or emotional disorders, restlessness, or clumsiness. She reiterates the need for careful evaluation (36:10)

Neuropsychiatric Aspects of Chorea in Children (Ebaugh, 1926)

The Prevalence of Neuropsychiatric Disorders in Sydenham’s Chorea (Ridel et al., 2010)

Obsessive compulsive behavior, hyperactivity, and attention deficit disorder in Sydenham chorea (Maia et al., 2005)

High prevalence of obsessive-compulsive symptoms in patients with Sydenham’s chorea. (Swedo et al., 1989)

Obsessive-Compulsive and Related Symptoms in Children and Adolescents With Rheumatic Fever With and Without Chorea: A Prospective 6-Month Study (Asbahr et al., 1998)

Sydenham’s Chorea: Physical and Psychological Symptoms of St Vitus Dance (Swedo et al., 1993)

The Emotional Correlates of Sydenham’s chorea (Freeman et al., 1963)

Mental Symptoms of Acute Chorea (Diefendor, 1912)

Rheumatic fever (Stollerman, 1997)

Erythema Marginatum 

Erythema Marginatum is a rash or skin lesion that occurs in SC and is brought out with heat (warm blankets or bath). Frankovich describes a case study of a 16-year-old with a long history of regressive behavior deterioration. He was initially diagnosed with SC; however, due to a lack of valve involvement, the diagnosis was removed. When he later presented with catatonia, clinicians wrapped him in warm blankets for 10 – 20 minutes and then observed his torso and limbs for rash patterns. The speaker notes that Erythema Marginatum patterns change every few minutes and that no other condition presents with such a rash (37:00)

Streptococcal infections, inflammation, and mental health

A recent population-based study on the association of streptococcal infection and mental disorders found the primary outcome of strep infections was a diagnosis of mental disorders, OCD, or tics (38:50). The speaker says it can be difficult to know if strep played a role in any child’s behavior, so we must rely on epidemiologists continue educating practitioners about the link between strep and mental disorders, especially OCD. 

A smaller study that compared school strep swabs to behaviors found a high correlation between positive strep throat cultures and the presence of tics, adventitious movements, and problem behaviors. Further, if the strep was recurring, the risk for abnormal movements was increased (40:00). Many animal models have also shown this correlation. 

 Association of streptococcal throat infection with mental disorders (Orlovska et al., 2017)

Relationship of Movements and Behaviors to Group A Streptococcus Infections in Elementary School Children (Murphy et al., 2007)

CNS Autoimmune Disease after Streptococcus Pyogenes Infections: Animal Models, Cellular Mechanisms and Genetic Factors (Cutforth et al., 2016)

Lupus 

Lupus, though a common condition, is relatively rare in children. However, 25% of children with Lupus also have neuropsychiatric symptoms such as headaches (66%), psychosis (36%), and cognitive dysfunction (27%). Similar to PANS, Lupus patients commonly have arthritis, small vessel vasculitis, and high immune complexities. They are also 10 – 15 times more likely to have OCD compared to patients without Lupus (42:00)

Resources

Frankovich thanks viewers and acknowledges research contributors. For more information on her research, visit med.stanford.edu/PANS. During the Q&A (44:55), the speaker answers questions about diagnosis, overlapping conditions, and much more.

Originally posted on October 1, 2024

The speakers:

Jennifer Frankovich: 

Dr. Frankovich is a Clinical Professor in the Department of Pediatrics, Division of Allergy, Immunology Rheumatology (AIR) at Stanford University/Lucile Packard Children’s Hospital (LPCH). Her clinical expertise is in systemic inflammatory and autoimmune diseases that co-occur with psychiatric symptoms. She completed her training in pediatrics, pediatric rheumatology, and clinical epidemiology at Stanford University/LPCH. She directs the Stanford Immune-Behavioral Health Program (2012- present) where she and her psychiatry/psychology collaborators have created a longitudinal clinical database and biorepository of patient and healthy control biospecimens. In addition to generating clinical data to better understand immune-behavioral health conditions, she is collaborating with basic science labs who aim to understand the immunological underpinnings of post-infectious neuropsychiatric conditions including PANS and related conditions.

Take the knowledge quiz

Can’t see the quiz below? Take it online HERE


  • Trauma Word Cloud

Autism and Trauma: Research Updates

March 11th, 2025|Adults on the Spectrum, Anxiety, Autism Spectrum Disorders, bullying, Challenging Behaviors, Gender, Health, Research, Self Care, seniors, Sensory, Sexuality, Social Skills, Ways to Help, Webinar|

Dr. Connor Kerns delivers research updates on the intersection of trauma and autism. She describes the relationship between childhood adversities, trauma, and mental health and highlights the need for trauma measurements that are

  • Support gesture. Woman comforting woman patient at group rehub meeting.

Wellbeing Wins: Integrating Positive Psychology into the Autism Community

January 2nd, 2025|Adults on the Spectrum, Anxiety, Anxiety, Back to School, depression, Executive Function, Health, Neurological, News, Self Care, Sleep Issues, Social Skills, Webinar|

Patricia Wright, PhD, MPH, and Katie Curran, MAAP, introduce Proof Positive - The Autism Well-being Alliance. The speakers describe positive psychology, its impact on well-being, and why it matters for autistic

The post Research Updates: At the Crossroads of Infection, Inflammation, and Mental Health appeared first on Autism Research Institute.

]]>
Research Update: Blood-brain barrier dysfunction in Pediatric Acute Neuropsychiatric Syndrome (PANS) and Regulation https://autism.org/blood-brain-barrier-dysfunction-in-pediatric-acute-neuropsychiatric-syndrome-pans-and-regulation/ Thu, 20 Jun 2024 21:04:11 +0000 https://autism.org/?p=17677 Dr. Jennifer Frankovich reviews what we know about the underlying mechanisms, trajectories, and symptoms of Pediatric Acute Neuropsychiatric Syndrome (PANS). She discusses the role of the Basal Ganglia in PANS symptoms and cites contemporary research that highlights this connection. Frankovich touches on the disruption of the blood-brain barrier and auto-antibody regulation

The post Research Update: Blood-brain barrier dysfunction in Pediatric Acute Neuropsychiatric Syndrome (PANS) and Regulation appeared first on Autism Research Institute.

]]>

Dr. Jennifer Frankovich reviews what we know about the underlying mechanisms, trajectories, and symptoms of Pediatric Acute Neuropsychiatric Syndrome (PANS). She discusses the role of the Basal Ganglia in PANS symptoms and cites contemporary research that highlights this connection. Frankovich touches on the disruption of the blood-brain barrier and auto-antibody regulation in PANS. 

Playback of Dr. Mondal’s presentation and Dr. Hussein’s presentation will be available at a future date.

In this webinar:

1:30 – PANS/PANDAS overview
3:10 – Underlying mechanisms
5:00 – Common symptoms
7:55 – PANS trajectories
9:35 – Basal Ganglia
13:12 – Antibodies and the blood-brain barrier

PANS/PANDAS

Frankovich outlines Pediatric Acute Neuropsychiatric Syndrome (PANS) and Pediatric Acute Neuropsychiatric Disorders Associated with Strep (PANDAS), underscoring the different triggers attributed to both conditions (1:30). Classification criteria for both PANS and PANDAS include a sudden onset of obsessive-compulsive disorder or eating restrictions along with at least two other co-occurring conditions like anxiety, sensory dysregulation, motor abnormalities, developmental regression, and deterioration of cognitive functioning (2:15)

Underlying mechanisms

Children with PANS-related symptoms often have some form of immune predisposition. The speaker explains that PANS occurs after a person gets an infection, which, due to predisposition, causes a systemic inflammatory response. She notes that these inflammatory responses may lead to Basal Ganglia inflammation, altered neuronal signaling, microbial activation, and more (3:10)

Common symptoms

The presenter describes classic PANS experiences, such as swelling in the knees, hips, and heel bones, back pain and inflammation, and evidence of psoriasis. She explains that children who experience their first case between the ages of five and ten will likely have arthritis by the time they are 14 (5:00). Frankovich highlights our bodies’ abilities to self-regulate inflammation, noting that in many cases, PANS symptoms are resolved on their own (7:15)

PANS Trajectories

There are generally four different trajectories for PANS:

  • Relapsing and remitting – returning to the same baseline
  • Relapsing and remitting – worsening baseline across time
  • Primary persistent – no return to baseline, remains in chronic episode
  • Secondary persistent – multiple episodes with increasing baseline until it reaches a chronic episode. 

Frankovich asserts that the primary and secondary persistent trajectories are likely more related to autoimmune predispositions than the others. Therefore, she continues, these trajectories require the most intense treatments and assessments (7:55)

Basal Ganglia

The Basal Ganglia (BG), a group of nuclei located beneath the cerebral cortex, has an inhibitory influence on motor and behavior systems. The speaker notes that inflammation, autoantibodies, and injury can disrupt the BG, affecting movements, mood, emotion, behavior, procedural learning, and cognition (9:35)

Frankovich briefly presents four brain imaging studies suggesting BG inflammation in PANS. She also discusses three studies indicating that patients experience abnormal movements during REM sleep cycles. These REM movements predict Parkinson’s in adults, making this a critical area of research and care (10:25)

Other physical signs of BG disruption include specific tongue and mouth movements. For example, a positive glabellar tap reflex is present in children with PANS, though it should disappear after infancy. Other abnormal tongue movements, like milkmaid grip, are discussed (11:55). The speaker notes that between 80 and 92% of patients in her clinic exhibit at least one sign of BG disruption (12:25).

19% of autistic youth also have a positive glabellar tap, and 27% have milkmaid grip tongue movements. The presenter, therefore, asserts that these BG signs are not unique to PANS and should be investigated carefully across groups (12:38)

Antibodies and the blood-brain barrier

PANS autoantibodies target interneurons and have been found in healthy kids and children with PANDAS. Frankovich explains that if these antibodies are causing problems in the body, it is because they are crossing the blood-brain barrier (BBB) (13:12). She highlights that current research suggests local disruptions to the BBB are associated with PANS symptoms (13:50).

Originally published on June 14, 2024

The speakers:

Jennifer Frankovich: 

Dr. Frankovich is a Clinical Professor in the Department of Pediatrics, Division of Allergy, Immunology Rheumatology (AIR) at Stanford University/Lucile Packard Children’s Hospital (LPCH). Her clinical expertise is in systemic inflammatory and autoimmune diseases that co-occur with psychiatric symptoms. She completed her training in pediatrics, pediatric rheumatology, and clinical epidemiology at Stanford University/LPCH. She directs the Stanford Immune-Behavioral Health Program (2012- present) where she and her psychiatry/psychology collaborators have created a longitudinal clinical database and biorepository of patient and healthy control biospecimens. In addition to generating clinical data to better understand immune-behavioral health conditions, she is collaborating with basic science labs who aim to understand the immunological underpinnings of post-infectious neuropsychiatric conditions including PANS and related conditions.

Publishing soon:

Noor A. Hussein, PhD is a pharmacology scientist.
“My experience as a researcher has taught me to seek out new perspectives for exploration and discovery. As a dedicated biological and pharmacological researcher with over 7 years of experience with models of diseases such as cancer both in vitro and in vivo. During my masters and Ph.D. studies, I mastered lots of molecular biology techniques, including cell culture, cytotoxicity assays, western blot, quantitative PCR, immunofluorescence, flow cytometry. I utilized my skills to design experiments finding solutions to common problems in the biomedical field, especially cancer experimental and molecular therapeutics.”

Ayan Mondal, Ph.D. is a third-year post-doctoral research fellow in Prof Elizabeth Mellins’ laboratory at Dept of pediatrics, Stanford University. “I completed my graduation from University of Calcutta, India, in 2017. I have conducted 1.5 years of research on molecular medicine following graduation and joined as a post-doctoral researcher at the Arnold School of Public health, University of South Carolina, in the year 2019. During the training, I studied neuroimmune signaling mechanisms in the gut-liver-brain axes in mouse models of metabolic disorders and military-deployment-associated disorders. My studies elucidated the mechanism of neuroinflammation and blood-brain barrier (BBB) dysfunction mediated by specific proteins that are elevated in blood during these disease conditions. In my post-doctoral research with Prof Mellins, I am studying changes in BBB function in PANS. I am focusing on elucidating the mechanisms of action of novel modulators of BBB that are relevant to homeostatic maintenance of the BBB and other novel modulators that increase BBB permeability during flares of PANS. My proposed experimental strategies include transcriptomic and proteomic approaches in cell types of the CNS neurovascular unit.”

 

Take the knowledge quiz

Can’t see the quiz below? Take it online HERE


  • Sad little child is hugging his mother

Research Update: Blood-brain barrier dysfunction in Pediatric Acute Neuropsychiatric Syndrome (PANS) and Regulation

June 20th, 2024|Anxiety, Assessment, Autism Spectrum Disorders, Biomarkers, Early Intervention, Health, Medical Care, Neurological, News, PANS/PANDAS, Parenting, Research, School Issues, Ways to Help, Webinar|

Dr. Jennifer Frankovich reviews what we know about the underlying mechanisms, trajectories, and symptoms of Pediatric Acute Neuropsychiatric Syndrome (PANS). She discusses the role of the Basal Ganglia in PANS symptoms

  • Boy has strep throat. Children's ENT doctor examines boy's throat. Children's diseases, medical examination.

PANS/PANDAS in Children with Autism

August 26th, 2020|Health, News, PANS/PANDAS|

The information below is from the 2019 ARI webinar, PANS/PANDAS - Research Updates In rare cases, some children may experience the sudden onset of Obsessive-Compulsive Disorder or eating disorders. This pediatric acute-onset

  • Lonely child with a sad expression in the yard

PANS/PANDAS

September 7th, 2018|Health, Immune Issues, Parenting, Webinar|

Free certificates of attendance are available upon successful completion of a brief knowledge quiz at: https://www.classmarker.com/online-te… Watch Dr. Sue Swedo’s presentation on the subset of individuals experiencing Obsessive/Compulsive Disorder symptoms and are

The post Research Update: Blood-brain barrier dysfunction in Pediatric Acute Neuropsychiatric Syndrome (PANS) and Regulation appeared first on Autism Research Institute.

]]>
Challenges of Medical Care for Seniors https://autism.org/medical-care-for-seniors-autism/ Wed, 12 Jan 2022 06:00:03 +0000 https://last-drum.flywheelsites.com/?p=14144 This is a joint presentation by ARI and The World Autism Organisation. Margaret Bauman, MD, discusses the many medical challenges those aging with autism face. She highlights the lack of medical training and research for adults and seniors with autism and underscores the need for increased education and advocacy. The

The post Challenges of Medical Care for Seniors appeared first on Autism Research Institute.

]]>
World Autism Org Collab image

This is a joint presentation by ARI and The World Autism Organisation.

Margaret Bauman, MD, discusses the many medical challenges those aging with autism face. She highlights the lack of medical training and research for adults and seniors with autism and underscores the need for increased education and advocacy. The speaker outlines challenges associated with preventative screenings, diagnosis of co-occurring conditions, primary care physicians, examination time constraints, and low government and health insurance reimbursement. Bauman speaks from her professional experiences and asserts the need for collaborative action to prepare for a better future. She closes with a question and answer session where she discusses guardian assignments and policy needs, disease prevalence in autism, and more.

Handouts are online HERE

In this webinar: 

0:00 – Petra Dilman – World Autism Organization
5:20 – Dr. Stephen Edelson – ARI
7:30 – Dr. Margaret Bauman – child psychologist and why she speaks on adult experiences
10:45 – Medical problems for aging autistic adults
12:00 – ER, hospitals and insurance providers
14:30 – Medical concerns for adults
18:20 – Provider limitations
21:20 – Incentives for primary care physicians
22:10 – Diagnostic challenges
24:30 – Atypical behaviors as signs of discomfort
27:14 – Behaviors that suggest GI discomfort
31:28 – Summary of diagnostic challenges
32:20 – Medical conditions
35:08 – Medically related conditions
38:10 – Mental health conditions
39:15 – Dementia surveys and queries
40:40 – Illnesses common in old age and lack of research
41:48 – Preventative screenings
43:34 – What needs to be done
46:33 – Parting words
48:20 – Q & A

Common medical challenges for autistic aging adults

Bauman emphasizes the importance of providing optimal – not minimal – medical care for adults and seniors with autism. She explains that due to the lack of medical care available to autistic adults, many pediatric practitioners have been obliged to carry on treating patients into adulthood (9:00). Presently, she continues, individual needs and proper support mechanisms for autistic adults and seniors remain largely unknown (7:30). Bauman lists some of the medical challenges faced by aging autistic adults (10:45) and discusses some in detail:

1. Finding primary care physicians (PCP) willing to accept adults with autism or who have any expertise or experience to do so. 

Few practitioners meet these parameters (11:30). Bauman describes this gap as a PCP shortage (18:25), noting the lack of medical education surrounding autism spectrum disorder. She states that, given the prevalence of autism, it is “inconceivable, regardless of what specialty somebody may eventually go into, that they aren’t going to come across one or more patients on the autism spectrum” (45:06). Further, time constraints on PCP visits (i.e., four 15-minute appointments per hour) do not allow enough time to assess many individuals with autism (19:00). Government medical records require thorough paperwork documentation as well, and there is relatively low Medicaid/Medicare reimbursement (20:40). Overall, she continues, incentives for PCP to take on patients with autism are minimal. Therefore, individuals needing such services often have to use academic hospitals where wait lists are three to six months long (21:20)

2. ER and hospital staff (12:00) and insurance providers (13:30) are not prepared to deal with the complex multiplicity of care that accompanies autism.

3. Medical conditions often present differently in adults with autism, creating diagnostic challenges (22:10)

For example, Bauman continues, autistic individuals often have difficulty verbalizing or pinpointing issues or discomfort (i.e., where it hurts, how it hurts, what the problem is) due to sensory processing differences and communication difficulties (23:40). She notes that atypical or disruptive behaviors may be signs of pain and discomfort, even if individuals cannot communicate their pain (24:30). The speaker shares personal experiences when she sent individuals with symptoms not generally associated with gastrointestinal (GI) issues to the gastroenterologist, where they were adequately diagnosed (24:50). She asserts that practitioners need to “… think beyond their own discipline” and consider unusual behaviors as interconnected. She reiterates that, due to the lack of education surrounding autism, even specialists may not know how to diagnose autistic adults and seniors (23:00) properly and urges viewers to “think beyond the obvious” (26:30). Bauman highlights the prevalence of GI issues in autism and asserts that practitioners and specialists must be trained on how differently symptoms present compared to the non-autistic population (30:30).  

Co-occurring conditions and mental health

The presenter lists medical conditions that commonly co-occur with autism, such as seizures, metabolic disorders, diabetes, and more (32:20). Bauman describes each condition and its relevance to autistic adults (33:30), noting the lack of routine screenings for adults and seniors with autism (41:48). She states that chronic pain, dental issues, sleep disorders, motor challenges, and even sensory processing issues can be significant factors that are part of, or contributing to, such medical conditions (35:08). Bauman touches on the acceleration of medical conditions with age, especially within the autistic population, and discusses gaps in research on diseases related to autistic adults and seniors (36:20)

Bauman asserts that there should be more stress on the mental health conditions associated with autism, especially during and following the pandemic (38:10). Such conditions include frequent mental distress, anxiety, depression, PTSD, social isolation, and dementia (38:10). She discusses recent studies showing an increased diagnosis of dementia in adults with autism and questions how one defines such conditions in individuals with potential developmental delays (39:15). Bauman highlights the evident lack of research and publications on other illnesses common in old age (i.e., multiple sclerosis, Alzheimer’s) (41:00) and posits that we have little idea what these issues look like in adults with autism (40:40)

Lifetime evaluation and care

The speaker reiterates the need to create methods by which we can begin to evaluate autistic seniors and adults in meaningful ways (44:10). She underscores that medical problems present in childhood often persist throughout the lifespan, along with other conditions that occur with aging (43:34). She tells of personal experiences consulting rehabilitation hospitals when autistic adults are admitted and notes how unprepared many are for communicating with and treating these patients (45:30). Bauman says that “family and professional advocacy for policy change is sorely needed” as it will take “several villages” to begin to understand how to effectively care for and assist autistic adults and seniors (46:18). She emphasizes preparing for the future and bringing greater awareness of the needs of aging autistic adults before opening the question and answer session (48:20)

About the speaker:

Margaret Bauman, MD, is a pioneer in the study and treatment of Autism and is highly respected by her fellow clinicians and patients for the level of clinical care she provides and the advances that she has contributed to in the field. Dr. Bauman is a Neurologist and specializes in the diagnosis and treatment of Autism and various neurological disorders in children, adolescents, and adults to include learning and developmental disabilities, seizures, cerebral palsy, and neurogenetic disorders. 

Take the knowledge quiz

Can’t see the quiz below? Take it online HERE

Evidence That Speaks: Prioritizing Proven Communication Supports for Non-Speaking Autistic Children

January 6th, 2026|Back to School, Educational Therapies, Meltdowns, Neurological, Research, Research, School Issues, Sensory, Uncategorized, Webinar|

Connie Kasari, PhD, details what contemporary research reveals about supporting non-speaking or minimally verbal autistic children. She highlights how far the field has come in the past two decades and emphasizes the

The post Challenges of Medical Care for Seniors appeared first on Autism Research Institute.

]]>
Executive Function and Autism https://autism.org/exeuctive-function-autism/ Mon, 22 Nov 2021 17:41:06 +0000 https://last-drum.flywheelsites.com/?p=13583 Greg Wallace, Ph.D., discusses executive functioning and its impacts on lived experiences across the lifespan in autism. He defines executive function (EF) as it relates to cognitive processes, the neuropsychological framework, and real-world outcomes. The presenter provides historical context for EF within autism, highlighting flexibility as the most common EF difficulty for

The post Executive Function and Autism appeared first on Autism Research Institute.

]]>

Greg Wallace, Ph.D., discusses executive functioning and its impacts on lived experiences across the lifespan in autism. He defines executive function (EF) as it relates to cognitive processes, the neuropsychological framework, and real-world outcomes. The presenter provides historical context for EF within autism, highlighting flexibility as the most common EF difficulty for autistic individuals. He outlines recent studies on EF profiles of autistic children, adolescents, and adults, underscoring the connection of EF to quality of life and successful daily living skills across autistic adulthood. Wallace highlights the critical importance of EF in real-world outcomes and notes the severe lack of support beyond early adulthood before the Q&A.

In this webinar: 

1:46 – Neuropsychological framework
3:28 – What is executive function (EF)
7:54 – EF and autism
13:36 – Lab-based vs real-world measures
16:32 – Behavior Rating Inventory EF (BRIEF)
19:08 – Research questions
20:38Study 1: EF profile of child/adolescent
24:11Study 2: EF profile young adults
26:30 – Conclusions: EF profiles in autistic children/adolescents and adults
28:52Study 3: Adult outcomes in autism
31:20 – Methods
36:30 – Results
39:09 – Daily living skills results
40:00 – Conclusion: EF outcomes across autistic adulthood
41:34 – Future research needs
43:26 – Summary and conclusions
45:15 – Q&A

What is executive function?

Wallace defines executive function (EF) as an umbrella term describing a set of cognitive processes that dictate behavioral regulation and influence the ability to attain proximal goals. These processes include working memory, cognitive flexibility, inhibitory control, and more (3:28). The speaker demonstrates how EF processes regulate thoughts, actions, and emotions to achieve goals like math homework, group chats, and adaptive functioning (5:41). Therefore, he continues, EF is critical to independence and our ability to function optimally in daily life as it provides context and longitudinal predictability for real-world outcomes (6:27)

EF was first linked to autism in the 1970s (7:54) and described using the Wisconsin Card Matching Test, which assesses cognitive flexibility (11:50). Cognitive flexibility, the most frequently occurring EF challenge in autism, affects one’s ability to transition from one activity to another, accept changes in routines, and manage violations of expectations (12:20)

Research questions and methods

Wallace details the Behavior Rating Inventory of Executive Function (BRIEF) (16:32) and presents research questions addressed by him and his team (19:40)

  1. What is the profile of real-world EF problems among autistic children, adolescents, and young adults? 
  2. Do these EF issues predict co-occurring psychopathology (i.e., anxiety and depression symptoms), which negatively impact outcomes in autistic children, adolescents, and young adults?

The speaker and his colleagues conducted three studies to address these questions. Each study utilized the BRIEF and a second rating scale specific to participant age and study purpose. Results split aspects of EF into two categories: the Behavior Regulation Index (BRI), which includes flexibility and inhibition, and the Metacognition Index (MI), which includes working memory and planning/organizing. Researchers ran controlled regressions (age and IQ) for each study.  

Study 1: Executive function profile of autistic children and adolescents

210 autistic children and adolescents (5 – 18 years old) without intellectual disability (83% male) completed the BRIEF and the Child Behavior Checklist (CBCL) (20:38). The EF profile showed clinically significant scores (1.5 standard deviations) across numerous domains, with the highest in flexibility (21:10). Regression analyses revealed that BRIEF indices predicted symptoms of depression and anxiety well beyond the influence of age and IQ. Specifically, BRI predicted anxiety symptoms, and BRI & MI predicted depression symptoms (22:33)

Study 2: Executive function profile of autistic young adults

Thirty-five autistic young adults without intellectual disability (31 male) completed the BRIEF and the Adult Behavior Checklist (ABCL) (24:11). Results showed high scores across the board, with planning and organizing as the most clinically significant. Regressions found that BRI predicted anxiety symptoms while MI (alone) predicted depression symptoms (24:51)

Wallace asserts that these two studies reveal autistic children, adolescents, and young adults have difficulties with flexibility. However, MI issues are more prominent than BRI issues in autistic young adults which could be due to earlier maturation of BRI in the non-autistic population or expectations of adulthood that align with MI skills (26:30). As MI and BRI predicted depression and anxiety symptoms, the speaker posits that EF as a treatment target could have positive downstream influences on co-occurring symptoms that negatively impact life satisfaction and quality (28:14)

Study 3: The role of executive function challenges in outcomes for autistic individuals

This study aimed to evidence the way EF challenges play in outcomes (community-based paid employment) for autistic individuals, especially those with intellectual disabilities (28:52). 628 participants with an autism diagnosis (59% female) from diverse socioeconomic backgrounds with an average age of 39 completed a series of self-reports and outcome measures (BDEFS, FS-R) as well as subjective quality of life (QoL) and daily living skills assessments (WHOQOL-BREF, ASQOL, W-ADL) (31:20). Controlled linear regressions (35:24) revealed that ER difficulties are related to lower physical and psychological QoL and that social relationship QoL decreases with autistic traits, and EF, and age. Increased EF correlates with lower autism-specific QoL (36:30), and living skills increased with age, although low inhibitory control and flexibility correspond with poorer daily living skills (39:09)

Conclusions

Based on these findings, Wallace concludes that EF is linked to subjective QoL and daily living skills outcomes across autistic adulthood. Further, he continues, such links between EF and adult outcomes suggest that differential interventions, accommodation, and support services must be based on a desired development or improvement (40:00). The speaker asserts that these studies evidence the critical importance of EF to real-world outcomes in autism. While intervention developments for children and adolescents are well underway, services and supports beyond early adulthood are severely lacking (43:26). Wallace touches on future research directions (41:34) before opening the question and answer session, where he discusses apparent gender biases and more (45:15).

For more information on this topic, watch our series on sensory processing in autism:

About the speaker:

Greg Wallace, Ph.D., is an Assistant Professor in the Department of Speech, Language, and Hearing Sciences at The George Washington University. His research focuses on neuropsychological and structural brain development in autism spectrum disorder and other neurodevelopmental disorders across the lifespan and their impacts on real-world outcomes. He is also particularly interested in eating-related behaviors and their cognitive and neural correlates in typical and atypical (e.g., autism spectrum disorder) development. Dr. Wallace has published extensively and presented his work widely on these and related topics.

Take the knowledge quiz

Can’t see the quiz below? Take it online HERE

  • Trauma Word Cloud

Autism and Trauma: Research Updates

March 11th, 2025|Adults on the Spectrum, Anxiety, Autism Spectrum Disorders, bullying, Challenging Behaviors, Gender, Health, Research, Self Care, seniors, Sensory, Sexuality, Social Skills, Ways to Help, Webinar|

Dr. Connor Kerns delivers research updates on the intersection of trauma and autism. She describes the relationship between childhood adversities, trauma, and mental health and highlights the need for trauma measurements that are

  • Support gesture. Woman comforting woman patient at group rehub meeting.

Wellbeing Wins: Integrating Positive Psychology into the Autism Community

January 2nd, 2025|Adults on the Spectrum, Anxiety, Anxiety, Back to School, depression, Executive Function, Health, Neurological, News, Self Care, Sleep Issues, Social Skills, Webinar|

Patricia Wright, PhD, MPH, and Katie Curran, MAAP, introduce Proof Positive - The Autism Well-being Alliance. The speakers describe positive psychology, its impact on well-being, and why it matters for autistic

  • Young child participating in sensory integration therapy session

Motor Skills and Executive Function in Autism

July 6th, 2024|Back to School, Early Intervention, Educational Therapies, Executive Function, Health, News, Parenting, Sensory, Social Skills|

Megan MacDonald, Ph.D., and Megan McClelland, Ph.D., discuss emerging research on the relationship between motor skill development and executive function in autism. They define motor skills and executive function, discuss their long-term impact

The post Executive Function and Autism appeared first on Autism Research Institute.

]]>
Systemic Inflammatory & Autoimmune Diseases—PANS https://autism.org/pans-and-autism-2021-updates/ Wed, 08 Sep 2021 18:45:21 +0000 https://last-drum.flywheelsites.com/?p=13029 Jennifer Frankovich MD MS, clinical professor at Stanford University/Lucile Packard Children’s Hospital, discusses the co-occurrence of systemic inflammatory and autoimmune diseases – including the overlap between pediatric acute-onset neuropsychiatric syndrome (PANS) and autism. She outlines the presentation of classic rheumatologic diseases noting the prevalence of mental health symptoms and provides clinical criteria

The post Systemic Inflammatory & Autoimmune Diseases—PANS appeared first on Autism Research Institute.

]]>

Jennifer Frankovich MD MS, clinical professor at Stanford University/Lucile Packard Children’s Hospital, discusses the co-occurrence of systemic inflammatory and autoimmune diseases – including the overlap between pediatric acute-onset neuropsychiatric syndrome (PANS) and autism. She outlines the presentation of classic rheumatologic diseases noting the prevalence of mental health symptoms and provides clinical criteria for PANS. Frankovich discusses PANS as a relapsing/remitting condition and explores the clinical management options, citing recent studies on steroid use. She concludes by reemphasizing the association of psychiatric symptoms with autoimmune and rheumatologic diseases and states the importance of post-flare rehabilitation before opening the floor to questions.

Take the knowledge quiz for this presentation HERE

In this presentation

3:20 – Inflammatory diseases with comorbid psychiatric symptoms
20:20 – PANS clinical criteria
34:54 – PANS model
22:15 – Prevalence of PANS comorbid traits
23:48 – Non-specific inflammatory signs
29:00 – Clinical Management of PANS
33:30 – Study: Impact of steroid treatments on PANS episode duration
37:15 – Study: Monocyte subsets associated with PANS clinical states
44:16 – Q & A session

Summary

Classic rheumatologic conditions such as Lupus (4:30), Behçet’s syndrome (5:43), Sjögren’s syndrome (9:30), Scleroderma (9:53), Spondyloarthritis (10:31), Inflammatory bowel disease (11:30), Psoriasis/Psoriatic Arthritis (12:03), CNS Vasculitis (13:05), and Sydenham Chorea (SC) (13:20) are associated with psychiatric symptoms such as OCD, anxiety, depression and/or other behavior changes. PANS (20:20) also presents with acute onset of OCD or eating disorders. These psychological comorbidities – specifically OCD – overlap with common symptoms of autism spectrum disorder making inflammatory diseases difficult to diagnose in children on the spectrum. Psychiatric symptoms in individuals with autism can distract from rheumatologic symptoms due to subtle/masked physical manifestations and/or communication difficulties. The onset of certain diseases – especially PANS – can also exacerbate psychological symptoms of ASD and often lead to autoimmune disease diagnosis (2:35).

There is a historic association of pediatric streptococcal throat infections with mental disorders – particularly OCD and tic disorders (18:00). This is especially true in cases of SC and PANS/PANDAS where patients generally present with symptoms 1 – 8 months after exposure to a Group A Streptococcal infection (13:20). Studies have also shown increased volume of basal ganglia during the first episode(s) of CS and PANS (18:42) demonstrating onset of encephalitis. PANS cases present with an acute onset of OCD or eating restrictions and at least 2 of seven comorbid symptoms (20:20). Patients display a very abrupt deterioration in performance, behavior, and mental stability – parents have described it as a personality shift overnight.

Clinical management of PANS (29:00) varies based on each patient. Treatments are generally approached in three stages:

  1.   Find and treat active infections (i.e. strep, sinusitis, etc.)
  2.   Treat post-infectious inflammation and autoimmunity (if present)
  3.   Note that inflammation can cause tissue injury making post-flare rehabilitation highly important (40:00)
  4.   Treat psychiatric symptoms

Post-infectious inflammation is often treated with steroids (NSAIDS, IVIG, etc.). 5 day oral steroid bursts have proven helpful if administered at the beginning of an episode and IVIG trials are taking shape currently (32:00). PANS is understood as a relapsing/remitting disease (21:35) and most patients will return to baseline within a few months after the initial episode. Later, likely following some sort of infection, they will have a relapse episode lasting around 3 months. If flares are caught quickly and treated properly, over time episode length can shrink. However, without treatment, after 4 or 5 flares the symptoms become more chronic (33:30). Episodes generally decrease with age but it is suspected that patients maintain the predisposition to episodes throughout their lifetime and a number of patients develop autoimmune diseases over time (27:30).

Frankovich concludes (38:42) by emphasizing the strong association of post-infectious inflammatory disorders and autoimmune diseases with psychiatric symptoms. She notes that psychiatric symptoms can precede full presentation of inflammatory conditions and urges clinicians and parents to use PANS evaluation guidelines when a child with ASD suddenly develops new psychiatric traits. During the Q&A Frankovich comments on differences between regressive autism and PANS, treatment options, limitations to diagnosis and clinician assistance, international programs and more.

For treatment recommendations and steroid regimens see appendix B of the treatment guidelines found at med.stanford.edu/PANS (publications tab).

About the speaker:

Dr. Jennifer Frankovich is a Clinical Professor in the Department of Pediatrics, Division of Allergy, Immunology Rheumatology (AIR) at Stanford University/Lucile Packard Children’s Hospital (LPCH). Her clinical expertise is in systemic inflammatory and autoimmune diseases that co-occur with psychiatric symptoms. She completed her training in pediatrics, pediatric rheumatology, and clinical epidemiology at Stanford University/LPCH. In addition to generating clinical data to better understand the PANS illness, she is collaborating with ten basic science labs who aim to understand the immunological underpinnings of the illness.

Take the knowledge quiz

Can’t see the quiz below? Take it online HERE

  • Sad little child is hugging his mother

Research Update: Blood-brain barrier dysfunction in Pediatric Acute Neuropsychiatric Syndrome (PANS) and Regulation

June 20th, 2024|Anxiety, Assessment, Autism Spectrum Disorders, Biomarkers, Early Intervention, Health, Medical Care, Neurological, News, PANS/PANDAS, Parenting, Research, School Issues, Ways to Help, Webinar|

Dr. Jennifer Frankovich reviews what we know about the underlying mechanisms, trajectories, and symptoms of Pediatric Acute Neuropsychiatric Syndrome (PANS). She discusses the role of the Basal Ganglia in PANS symptoms

  • Anxious young girl covering her face

Autism and Anxiety

September 14th, 2020|Anxiety, News|

Anxiety disorders are among the common comorbidities of autism spectrum disorder. The reason for this overlap is still under investigation. However, several treatments for anxiety may deliver positive results for people with

  • Boy has strep throat. Children's ENT doctor examines boy's throat. Children's diseases, medical examination.

PANS/PANDAS in Children with Autism

August 26th, 2020|Health, News, PANS/PANDAS|

The information below is from the 2019 ARI webinar, PANS/PANDAS - Research Updates In rare cases, some children may experience the sudden onset of Obsessive-Compulsive Disorder or eating disorders. This pediatric acute-onset

  • Lonely child with a sad expression in the yard

PANS/PANDAS

September 7th, 2018|Health, Immune Issues, Parenting, Webinar|

Free certificates of attendance are available upon successful completion of a brief knowledge quiz at: https://www.classmarker.com/online-te… Watch Dr. Sue Swedo’s presentation on the subset of individuals experiencing Obsessive/Compulsive Disorder symptoms and are

The post Systemic Inflammatory & Autoimmune Diseases—PANS appeared first on Autism Research Institute.

]]>
PANS/PANDAS in Children with Autism https://autism.org/pans-pandas-in-children-with-autism/ Wed, 26 Aug 2020 09:58:21 +0000 https://last-drum.flywheelsites.com/?p=8628 The information below is from the 2019 ARI webinar, PANS/PANDAS - Research Updates In rare cases, some children may experience the sudden onset of Obsessive-Compulsive Disorder or eating disorders. This pediatric acute-onset neuropsychiatric syndrome is commonly called PANS. PANDAS is a subtype of PANS with a specific known cause, exposure to a

The post PANS/PANDAS in Children with Autism appeared first on Autism Research Institute.

]]>

The information below is from the 2019 ARI webinar, PANS/PANDAS – Research Updates

In rare cases, some children may experience the sudden onset of Obsessive-Compulsive Disorder or eating disorders. This pediatric acute-onset neuropsychiatric syndrome is commonly called PANS. PANDAS is a subtype of PANS with a specific known cause, exposure to a strep infection. While PANS/PANDAS occurs mostly in children who do not also have Autism Spectrum Disorder, in rare cases, a child may have both conditions. Recognizing and diagnosing PANS/PANDAS in a child with ASD can be especially challenging because many of the symptoms overlap.

Signs and Symptoms of PANS/PANDAS

Between 1 and 3% of youths have OCD. Among children with OCD, up to 5% may meet the criteria for PANS/PANDAS. While as many as 17% of children with autism also have OCD, it is very rare that their OCD is linked to PANDAS. Even so, the situation can arise. When it does, it can be difficult to separate the symptoms of autism from signs of PANS/PANDAs since many of the symptoms and comorbidities overlap.

While PANS is a group of symptoms without an undetermined cause, PANDAS does have a clear trigger. In most cases, the onset of PANDAS is triggered by exposure to Group A Streptococci, commonly known as strep throat or a strep infection. Other microbes, including Lyme and Mycoplasma, may also be related to PANDAS. When a child with genetic susceptibility (2-5% of the population) is exposed to these microbes, it causes a misdirected immune response, which leads to brain inflammation. This can manifest as PANDAS. 

Boy has strep throat. Children's ENT doctor examines boy's throat. Children's diseases, medical examination.

PANS/PANDAS is marked by the abrupt onset of OCD or Anorexia. With the concurrent onset of at least two of seven signs:

  1. Anxiety
  2. Behavioral developmental regression
  3. Emotional liability or depression
  4. Irritability aggression or severally oppositional behavior
  5. Deterioration in school performance
  6. Sensory or motor abnormalities
  7. Somatic signs/symptoms, especially insomnia and urinary symptoms

PANDAS is essentially a form of autoimmune encephalitis, a complex set of brain disorders, characterized by autoimmune induced neuroinflammation. It is diagnosed only when symptoms are not better explained by other neurologic or medical disorders such as Sydenham’s chorea or Tourette Syndrome.

Who gets PANS/PANDAS?

By definition, PANS/PANDAS affects children. While it may be diagnosed in children between the ages of 3 and 12, the average age of onset is between 7 and 8 years old. It is most common in children between Kindergarten and second grade.

PANS/PANDAS seems to affect all socio-demographic groups equally. However, researchers have noticed increased rates of these conditions in families with a history of acute rheumatic fever or OCD. For a more in-depth look into the history and impacts of PANDAS, view the webinars Research Updates – PANS/PANDAS by Dr. Susan Swedo, who led the NIMH team that was first to identify this new subtype of pediatric OCD and and our latest webinar Systemic Inflammatory & Autoimmune Diseases—PANS  by Jennifer Frankovich, MD, MS.

Dr. Swedo describes comorbidities as a rule, rather than the exception, in children with PANDAS. Common Comorbidities include:

  • Sleep disorders (80%)
  • Behavioral regression (98%)
  • Inability to concentrate (90%)
  • Handwriting deterioration (90%)
  • Urinary frequency, urgency, enuresis (90%)

Only about 10% have hallucinations, and about 20% have eating disorders. More common comorbidities include short-term memory loss, hyperactivity, aggressiveness, learning difficulties, and sensory hypersensitivity.

How PANS/PANDAS is diagnosed

Diagnosis of PANS/PANDAS is based on the consensus statement from the PANS Consensus Conference, published in the Journal of Child and Adolescent Psychopharmacology in 2015. PANS/PANDAS requires a differential diagnosis, meaning that the symptoms cannot be better caused by another known medical or neurological disorder. Other diagnoses might include:

  • Lupus
  • Steroid responsive encephalitis
  • Multiple sclerosis
  • Guillain Barre syndrome
  • A different form of Autoimmune encephalitis
  • Other disorders

Before diagnosing PANDAS, a physician may order laboratory testing, EEG and MRI scans, or a sleep study. They will likely take a comprehensive family history (paying special attention to genetic factors and exposure to strep), perform a physical examination, and look for involuntary movements and dilation of the pupils. If the onset is recent, the clinician may also take a throat culture to identify the presence of a strep infection. Remember that PANDAS can only be diagnosed if the symptoms cannot be explained by another disorder. Clinicians should seek to rule out other illnesses first.

How is it treated

Clinicians generally take a three-prong approach to treating PANDAS.  

1. Treating and preventing infections: If the child has a bacterial infection, treating this infection can reduce symptoms and improve outcomes, especially during the first weeks or months of illness. In this case, a physician may prescribe 3 to 4 weeks of narrow-spectrum antibiotics.

2. Addressing immune system dysfunction: Immunomodulatory therapies to address immune system dysfunction may include NSAID’s Oral or IV steroids, intravenous immunoglobulin (IVIG), therapeutic plasmapheresis, and others indicated by severity. These are only useful in conjunction with infection treatment and psychiatric and behavioral interventions.

If a child has OCD but does not have PANS/PANDAS, there is no reason to pursue a long-term immune treatment. In a study by Nicolson et al, JAACAP 2000, children with OCD but without PANS/PANDAS saw no significant improvement from therapeutic plasma exchange. These therapies are expensive and intensive. Other studies have shown similar results.

3. Applying Behavioral and Psychiatric Interventions: Behavioral and psychiatric Interventions may include SSRI’s Anxiolytics, Soporifics, other typical psychiatric medications, and cognitive behavior therapy. When choosing a therapist, Dr. Swedo suggests looking for an expert in OCD treatment:

“If I had my choice between a therapist who had a lot of experience treating children or one who had a lot of experience treating OCD in adults, I would actually go for the treatment of OCD in adults because treatment of OCD in children is identical to that has been found to be effective for adult patients with obsessive-compulsive disorder,” she said.

Supportive therapy can help parents understand the course of illness and treatment. Getting parents into CBT even before the child is ready can be very helpful.

Treatments should be administered by a licensed and qualified healthcare provider. If you suspect your child may have PANS or PANDAS, consult your primary care physician.

In very rare cases, a child with autism may also qualify for a diagnosis of PANS/PANDAS. For a deeper look at the latest PANS/PANDAS research, view the webinar presented by Susan Swedo, M.D. and our latest webinar Systemic Inflammatory & Autoimmune Diseases—PANS  by Jennifer Frankovich, MD, MS.

For more information, visit the PANDAS Physicians Network.

ARI thanks Sue Swedo, MD, for her contributions to this article. 

  • Sad little child is hugging his mother

Research Update: Blood-brain barrier dysfunction in Pediatric Acute Neuropsychiatric Syndrome (PANS) and Regulation

June 20th, 2024|Anxiety, Assessment, Autism Spectrum Disorders, Biomarkers, Early Intervention, Health, Medical Care, Neurological, News, PANS/PANDAS, Parenting, Research, School Issues, Ways to Help, Webinar|

Dr. Jennifer Frankovich reviews what we know about the underlying mechanisms, trajectories, and symptoms of Pediatric Acute Neuropsychiatric Syndrome (PANS). She discusses the role of the Basal Ganglia in PANS symptoms

  • Baby at the doctor’s office during a check-up

Co-Occurring Conditions and Autism

January 10th, 2022|News, Uncategorized|

Research suggests that individuals with autism experience some conditions―including underlying medical issues, neurodevelopmental differences, and mental health issues―more frequently than the general population. Learning about these potential medical needs can help you

The post PANS/PANDAS in Children with Autism appeared first on Autism Research Institute.

]]>